Trial intelligence / Profile preview

Oral ondansetron added to care-as-usual for persisting vomiting in pediatric gastroenteritis

2016-003582-25Phase 4Active

Sponsor
University Medical Center Groningen
Start
Sep 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ondansetron in gastroenteritis (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Number of children with persisting vomiting during the first 4 hours. Started Sep 2016; status: active.

02

Drugs

ondansetron
03

Conditions

gastroenteritis

Beyond the preview

Go deeper on 2016-003582-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-003582-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call